DePuy Orthopeadics, a subunit of Johnson & Johnson, will pay more than $2.5 billion to settle metal-on-metal hip implant lawsuits.
The settlement was announced in November 2013, and late last month the company waived its “walk-away rights” and will begin paying plaintiffs.
Patients who had to get a second operation as the result of a faulty or failed ASR hip implant will be receiving payments from the Warsaw-based company. 7,200 American patients agreed to the settlement; ...
continue reading...
In January of 2013, the Federal Food and Drug Administration (FDA) issued a safety communication advising healthcare professionals and the general public regarding the 
The National Law Journal is reporting that the first federal trial involving DePuy Orthopaedic Inc.’s metal-on-metal hip implant devices is set to begin on September 9, 2013 in Cleveland, Ohio. This is the first of nearly 8,000 cases currently being coordinated in a multidistrict litigation (MDL) before Judge David Katz.
According to a Bloomberg story, nearly 16,800
